Janssen Presents Initial Results from the Phase 2 RAGNAR Study of BALVERSA ® (erdafitinib) in Patients with Advanced Solid Tumors with FGFR Alterations
CHICAGO, ILLINOIS, June 7, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced initial results from the pivotal Phase 2 RAGNAR study evaluating the investigational use of BALVERSA® (erdafitinib), a fibroblast growth factor receptor (FGFR) kinase inhibitor, in patients with advanced solid tumors with prespecified FGFR alterations. At a planned interim analysis (IA), responses were observed across a variety of FGFR-driven solid tumors for patients who had exhausted standard treatment options prior to being treated with BALVERSA®.[1] These results will be featured in an oral presentation (...
Source: Johnson and Johnson - June 7, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news
Namibia: Thousands in 'Lucky Draw' for 48 Vaccination Posts
[Namibian] THOUSANDS of unemployed candidates flocked to the offices of the Zambezi regional Directorate of Veterinary Services (DVS) yesterday to have a chance at 48 temporary positions in an apparent draw.THOUSANDS of unemployed candidates flocked to the offices of the Zambezi regional Directorate of Veterinary Services (DVS) yesterday to have a chance at 48 temporary positions in an apparent draw. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - June 4, 2022 Category: African Health Source Type: news
Phase 3 SHINE Results Show IMBRUVICA ® (ibrutinib)-Based Combination Regimen Significantly Reduced the Risk of Disease Progression or Death in Older Patients with Newly Diagnosed Mantle Cell Lymphoma
This study is one of the largest clinical trials ever conducted in first-line MCL and the first for a Bruton’s tyrosine kinase inhibitor (BTKi).[1] The data are being presented in an oral session and featured in a press briefing during the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting, and were published in The New England Journal of Medicine today. The data will also be presented as an oral presentation at the 2022 European Hematology Association (EHA) Annual Congress. MCL is a type of aggressive, rare non-Hodgkin lymphoma (NHL) that is incurable and difficult to treat.[2] It commonly affects people o...
Source: Johnson and Johnson - June 3, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news
Kenya: People Will Continue to Die of Rabies If Kenya Doesn't Educate Healthcare Workers
[The Conversation Africa] Rabies - a viral disease spread through an animal bite - has had an effective vaccine for more than a century. Yet people continue to die from it. Rabies kills nearly every known person that shows clinical signs of it, making it arguably one of the world's deadliest infectious diseases. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - June 3, 2022 Category: African Health Source Type: news
Janssen to Highlight Science, Innovation and Advances in Robust Oncology Portfolio and Pipeline Through More Than 60 Data Presentations at ASCO and EHA
RARITAN, N.J., May 31, 2022 — The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that new research and data from its robust oncology portfolio and pipeline of investigational therapies will be presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place June 3-7 in Chicago, and the European Hematology Association (EHA) 2022 Congress taking place in Vienna, Austria, June 9-12. More than 60 presentations from company-sponsored studies across the two congresses, including 14 oral presentations, will feature new data and updates for both approved and investigation...
Source: Johnson and Johnson - May 31, 2022 Category: Pharmaceuticals Source Type: news
Mozambique: Foot-and-Mouth Disease Vaccines Imported
[AIM] The veterinary authorities have started to import 1.5 million doses of vaccine against foot-and-mouth disease in response to an outbreak in the districts of Chifunde and Maravia, in the central province of Tete. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 31, 2022 Category: African Health Source Type: news
Monkeypox Won ’t Turn Into a Pandemic, the WHO Says, but There Are Many Unknowns
LONDON — The World Health Organization’s top monkeypox expert said she doesn’t expect the hundreds of cases reported to date to turn into another pandemic, but acknowledged there are still many unknowns about the disease, including how exactly it’s spreading and whether the suspension of mass smallpox immunization decades ago may somehow be speeding its transmission.
In a public session on Monday, WHO’s Dr. Rosamund Lewis said it was critical to emphasize that the vast majority of cases being seen in dozens of countries globally are in gay, bisexual or men who have sex with men, so that scient...
Source: TIME: Health - May 31, 2022 Category: Consumer Health News Authors: MARIA CHENG / AP Tags: Uncategorized Disease overnight wire Source Type: news
Q & A: What you need to know about monkeypox
Monkeypox burst into the headlines this month after cases were diagnosed in Africa, Europe, North America and Australia.In an interview,Anne Rimoin, the Gordon-Levin Professor of Infectious Diseases and Public Health at the UCLA Fielding School of Public Health, offered insights about the disease, which she has studied for two decades. Rimoin has been director of theUCLA Center for Global and Immigrant Health and is the founder of the UCLA –DRC Health Research and Training Program in the Democratic Republic of the Congo.In simplest terms, what is monkeypox?Monkeypox is a viral zoonosis, a virus that is transmitted from a...
Source: UCLA Newsroom: Health Sciences - May 26, 2022 Category: Universities & Medical Training Source Type: news
Mozambique: Vaccines Imported Against Foot-and-Mouth Disease
[AIM] Maputo -- The Mozambican veterinary authorities have started to import one and a half million doses of vaccine against foot-and-mouth disease to respond to the outbreak of this livestock disease, which has already been confirmed in the districts of Chifunde and Mar ávia, in the central province of Tete. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 26, 2022 Category: African Health Source Type: news
Roche develops unique PCR tests to detect the monkeypox virus
Roche and its subsidiary TIBMolbiol have developed three differentLightMix® Modular Virus kits for the detection of themonkeypox virusMultiple clusters ofmonkeypox virus have been reported in non-endemic countries, and the World Health Organization (WHO) expects more cases will be identified as surveillance expandsUse of these new research test kits assess the spread of the virus and can help monitor the potential impact of therapeutics, vaccines and public health interventionsBasel, 25 May 2022 – Roche (SIX: RO, ROG; OTCQX: RHHBY) and its subsidiary TIB Molbiol have developed three unique LightMix® Modular Virus kits ...
Source: Roche Media News - May 25, 2022 Category: Pharmaceuticals Source Type: news
Roche develops unique PCR tests to detect the monkeypox virus
Roche and its subsidiary TIB Molbiol have developed three different LightMix ® Modular Virus kits for the detection of the monkeypox virus Multiple clusters of monkeypox virus have been reported in non-endemic countries, and the World Health Organization (WHO) expects more cases will be identified as surveillance expandsUse of these new research test kits assess the spread of the virus and can help monitor the potential impact of therapeutics, vaccines and public health interventionsBasel, 25 May 2022 – Roche (SIX: RO, ROG; OTCQX: RHHBY) and its subsidiary TIB Molbiol have developed three unique L...
Source: Roche Media News - May 25, 2022 Category: Pharmaceuticals Source Type: news
There ’s Already a Monkeypox Vaccine. But Not Everyone May Need It
Case counts of monkeypox continue to grow worldwide, raising concerns about how people can protect themselves. So far, the World Health Organization reports that in 12 countries, 92 cases have been confirmed in this recent emergence of the virus, and 28 possible cases are still being investigated. What alarms public health officials about the recent outbreaks is that monkeypox is generally not common or known to circulate in these nations; it’s endemic in parts of central and western Africa, but not in the European and North American nations—including the U.S.—that are currently seeing an uptick in infect...
Source: TIME: Health - May 23, 2022 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate Public Health Source Type: news
There ’ s Already a Monkeypox Vaccine. But Not Everyone May Need It
Case counts of monkeypox continue to grow worldwide, raising concerns about how people can protect themselves. So far, the World Health Organization reports that in 12 countries, 92 cases have been confirmed in this recent emergence of the virus, and 28 possible cases are still being investigated. What alarms public health officials about the recent outbreaks is that monkeypox is generally not common or known to circulate in these nations; it’s endemic in parts of central and western Africa, but not in the European and North American nations—including the U.S.—that are currently seeing an uptick in infect...
Source: TIME: Health - May 23, 2022 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate Public Health Source Type: news
Rabies in a Dog Imported from Azerbaijan - Pennsylvania, 2021
This report describes a case of rabies in a dog imported from Azerbaijan to the United States. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - May 19, 2022 Category: American Health Tags: Animal-Related Diseases Dog Bites Dogs, Infections from MMWR Morbidity & Mortality Weekly Report Pets Animals Rabies Rabies Vaccine Vaccination Vaccines Source Type: news
As COVID Wanes, Tuberculosis Deaths Must Become Visible
Tuberculosis has killed 1,5 million people in 2020 - mostly in African and Asian countries - while two million people died of COVID-19 worldwide during the same period. Credit: Athar Parvaiz/IPSBy Angelique Luabeya Kany KanyCAPE TOWN, South Africa, May 19 2022 (IPS) It is time to treat the scourge of Tuberculosis scourge with the same urgency as we did the COVID-19 pandemic.
As we emerge from the devastating toll of the pandemic on people’s lives and on global economies, we must wake up to face the staggering toll of 1.5 million Tuberculosis deaths and 10 million new infections recorded in 2020. And these deaths wer...
Source: IPS Inter Press Service - Health - May 19, 2022 Category: International Medicine & Public Health Authors: Angelique Luabeya Kany Kany Tags: Africa Headlines Health Poverty & SDGs TerraViva United Nations tuberculosis Source Type: news
